CMH :: Clinical and Molecular Hepatology

REVIEW KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

ORIGINAL ARTICLE Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
Background/Aims: Hepatitis C virus (HCV) replicates in the peripheral blood mononuclear cells (PBMCs), leading to the production of type I interferons (IFNs). It is well known that the gene expression profile of PBMC is similar to that of the liver. The present study explored th...

ORIGINAL ARTICLE Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Background/Aims: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 in...

Current Issue

Volume 24(3); Sep 2018

Volume 24(2); June 2018

Volume 24(1); March 2018

Volume 23(4); December 2017

Volume 23(3); September 2017

Most-cited are based on citations from 2016 ~ 2018.

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol.2016;22(1):7-17. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.7

Cited By 65

KASL clinical practice guidelines: management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol.2016;22(1):18-75. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.18

Cited By 54

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol.2017;23(1):1-12. Published online March 9, 2017
DOI: https://doi.org/10.3350/cmh.2016.0109

Cited By 27

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol.2016;22(1):76-139. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.76

Cited By 21

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol.2016;22(1):160-167. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.160

Cited By 17

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol.2016;22(3):319-326. Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0045

Cited By 16

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol.2016;22(3):327-335. Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0049

Cited By 15

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis

Gaeun Kim, Moon Young Kim, Soon Koo Baik

Clin Mol Hepatol.2017;23(1):34-41. Published online March 7, 2017
DOI: https://doi.org/10.3350/cmh.2016.0059

Cited By 15

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease

Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani

Clin Mol Hepatol.2016;22(1):146-151. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.146

Cited By 14

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol.2016;22(4):415-422. Published online December 14, 2016
DOI: https://doi.org/10.3350/cmh.2016.0056

Cited By 14

Current status of laparoscopic liver resection for hepatocellular carcinoma

Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy

Clin Mol Hepatol.2016;22(2):212-218. Published online June 15, 2016
DOI: https://doi.org/10.3350/cmh.2016.0026

Cited By 13

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm

Chansik An, Gulbahor Rakhmonova, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol.2016;22(2):296-307. Published online June 15, 2016
DOI: https://doi.org/10.3350/cmh.2016.0028

Cited By 13

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol.2016;22(2):219-237. Published online June 13, 2016
DOI: https://doi.org/10.3350/cmh.2016.0024

Cited By 12

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol.2016;22(4):423-431. Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0069

Cited By 12

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol.2016;22(1):1-6. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.1

Cited By 11

Liver transplantation for advanced hepatocellular carcinoma

Hae Won Lee, Kyung-Suk Suh

Clin Mol Hepatol.2016;22(3):309-318. Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0042

Cited By 11

What we need to know when performing and interpreting US elastography

So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee

Clin Mol Hepatol.2016;22(3):406-414. Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0106

Cited By 10

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol.2016;22(4):432-438. Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0107

Cited By 10

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol.2016;22(2):250-258. Published online June 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0015

Cited By 8

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol.2016;22(2):199-211. Published online May 18, 2016
DOI: https://doi.org/10.3350/cmh.2016.0101

Cited By 7

The Korean Association for the Study of the Liver